It is normal to feel disappointed. Frankly, I wish they had sat down, brainstormed and focused on one promising trial (instead of a multitude of trials) that would have given the biggest bang for the buck, and got into phase 3 that much quicker while seeking some partnership. That would have set the pps in motion. Instead, every other month we have some update of either phase 1 or phase 2 with the first patient being dosed or some PR stating that progress is being made in the trials. The India trial and the Canine trial took the wind out of the sails and we drifted course.